The incidence of diabetes is increasing at an alarming rate, and regular glucose monitoring
is critical in order to manage diabetes. Currently, glucose in the body is measured by an …

The year 2021 marks the centennial of Banting and Best's landmark description of the
discovery of insulin. This discovery and insulin's rapid clinical deployment effectively …

Poor adherence to drug dosing schedule is responsible for∼ 50% of hospitalization cases.
Most patients fail to adhere to a strict dosing schedule due to invasive drug administration …

Continuous glucose monitoring (CGM) technology has evolved over the past decade with
the integration of various devices including insulin pumps, connected insulin pens (CIPs) …

Microneedle (MN) technologies offer the opportunity to improve patient access and target
delivery of drugs and vaccines to specific tissues. When in the form of skin patches, MNs can …

Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Currently, there are about 150–200 million diabetic patients treated with insulin globally. The
year 2021 is special because the 100th anniversary of the insulin discovery is being …

The management of diabetes in a manner offering autonomous insulin therapy responsive
to glucose‐directed need, and moreover with a dosing schedule amenable to facile …

Diabetes is a chronic disease affecting 10% of the population globally, and can lead to
serious damage in the heart, kidneys, eyes, blood vessels or nerves. Commercial artificial …

Key Clinical Points Current Management of Glycemia in Children with Type 1 Diabetes
Mellitus Type 1 diabetes mellitus is one of the most common chronic diseases of childhood …